|Bid||1.2600 x 0|
|Ask||1.2800 x 0|
|Day's Range||1.2550 - 1.2850|
|52 Week Range||1.0500 - 1.7150|
|Beta (5Y Monthly)||0.52|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Volpara Health, (ASX: VHT), a global health technology software leader providing an integrated platform for the delivery of personalized breast and lung care, further expanded its footprint in the US lung screening market with a strategic relationship with Seattle-based lung AI company RevealDx. This follows Volpara's recent collaboration agreement with leading US lung imaging company Riverain Technologies.
Volpara Health (ASX: VHT), a health technology software company whose integrated breast care platform assists in the delivery of personalized patient care, is pleased to announce the acquisition of CRA Health, LLC, a breast cancer risk assessment company spinoff from Massachusetts General Hospital — a Harvard Medical School teaching hospital.